{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:13:30Z","timestamp":1760112810912,"version":"build-2065373602"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microbial Pathogenesis"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.micpath.2022.105736","type":"journal-article","created":{"date-parts":[[2022,8,24]],"date-time":"2022-08-24T11:48:11Z","timestamp":1661341691000},"page":"105736","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Preparation and pre-clinical evaluation of flagellin-adjuvanted NOM vaccine candidate formulated with Spike protein against SARS-CoV-2 in mouse model"],"prefix":"10.1016","volume":"171","author":[{"given":"Narges","family":"Farshidi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tayebeh","family":"Ghaedi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehdi","family":"Hassaniazad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ebrahim","family":"Eftekhar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamed","family":"Gouklani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hossein","family":"Farshidi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Reza","family":"Asadi Karam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Behzad","family":"Shahbazi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehdi","family":"Kalani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khadijeh","family":"Ahmadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.micpath.2022.105736_bib1","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1016\/j.sjbs.2020.04.033","article-title":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): emergence, history, basic and clinical aspects","volume":"27","author":"Al-Qahtani","year":"2020","journal-title":"Saudi J. Biol. Sci."},{"year":"2021","series-title":"Enhancing Public Trust in COVID-19 Vaccination: the Role of Governments","key":"10.1016\/j.micpath.2022.105736_bib2"},{"key":"10.1016\/j.micpath.2022.105736_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41541-021-00369-6","article-title":"Distinguishing features of current COVID-19 vaccines: knowns and unknowns of antigen presentation and modes of action","volume":"6","author":"Heinz","year":"2021","journal-title":"npj Vaccines"},{"year":"2021","series-title":"Active Site\u2010based Analysis of Structural Proteins for Drug Targets in Different Human Coronaviruses","author":"Ahmadi","key":"10.1016\/j.micpath.2022.105736_bib4"},{"key":"10.1016\/j.micpath.2022.105736_bib5","article-title":"Understanding the role of SARS-CoV-2 ORF3a in viral pathogenesis and COVID-19","volume":"13","author":"Zhang","year":"2022","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.micpath.2022.105736_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.jksus.2020.101335","article-title":"Comparison of the SARS-CoV-2 (2019-nCoV) M protein with its counterparts of SARS-CoV and MERS-CoV species","volume":"33","author":"Alharbi","year":"2021","journal-title":"J. King Saud Univ. Sci."},{"key":"10.1016\/j.micpath.2022.105736_bib7","first-page":"118","article-title":"The M protein of SARS-CoV: basic structural and immunological properties","volume":"1","author":"Hu","year":"2003","journal-title":"Dev. Reprod. Biol."},{"key":"10.1016\/j.micpath.2022.105736_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12985-020-01437-4","article-title":"Prediction and evolution of B cell epitopes of surface protein in SARS-CoV-2","volume":"17","author":"Lon","year":"2020","journal-title":"Virol. J."},{"key":"10.1016\/j.micpath.2022.105736_bib9","doi-asserted-by":"crossref","first-page":"4951","DOI":"10.3390\/ijms22094951","article-title":"IgM and IgG immunoreactivity of SARS-CoV-2 recombinant M protein","volume":"22","author":"Lopandi\u0107","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.micpath.2022.105736_bib10","article-title":"Cellular responses to Membrane and Nucleocapsid viral proteins are also boosted after SARS-CoV-2 Spike mRNA vaccination in individuals with either past infection or cross-reactivity","volume":"12","author":"Vallejo","year":"2021","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.micpath.2022.105736_bib11","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1016\/j.csbj.2021.04.061","article-title":"An overview of current COVID-19 vaccine platforms","volume":"19","author":"Nagy","year":"2021","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.micpath.2022.105736_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-020-73179-w","article-title":"In silico analysis and in vivo assessment of a novel epitope-based vaccine candidate against uropathogenic Escherichia coli","volume":"10","author":"Hasanzadeh","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.micpath.2022.105736_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41541-021-00292-w","article-title":"SARS-CoV-2 vaccines strategies: a comprehensive review of phase 3 candidates","volume":"6","author":"Kyriakidis","year":"2021","journal-title":"npj Vaccines"},{"key":"10.1016\/j.micpath.2022.105736_bib14","first-page":"52","article-title":"The role of Toll-like receptors (TLR) in innate and adaptive immune responses and their function in immune response regulation","volume":"60","author":"Majewska","year":"2006","journal-title":"Post\u0119py Higieny Medycyny Do\u015bwiadczalnej"},{"key":"10.1016\/j.micpath.2022.105736_bib15","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1128\/CVI.00669-13","article-title":"Flagellin a toll-like receptor 5 agonist as an adjuvant in chicken vaccines","volume":"21","author":"Gupta","year":"2014","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.micpath.2022.105736_bib16","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1021\/mp500520r","article-title":"Flagellin as carrier and adjuvant in cocaine vaccine development","volume":"12","author":"Lockner","year":"2015","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.micpath.2022.105736_bib17","article-title":"Local induction of bladder Th1 responses to combat urinary tract infections","volume":"118","author":"Wu","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.micpath.2022.105736_bib18","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1080\/07391102.2020.1756411","article-title":"Reverse vaccinology approach to design a novel multi-epitope vaccine candidate against COVID-19: an in silico study","volume":"39","author":"Enayatkhani","year":"2021","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.micpath.2022.105736_bib19","series-title":"The Proteomics Protocols Handbook","first-page":"571","article-title":"Protein identification and analysis tools on the ExPASy server","author":"Gasteiger","year":"2005"},{"key":"10.1016\/j.micpath.2022.105736_bib20","series-title":"Prediction of Protein Secondary Structure","first-page":"7","article-title":"The GOR method of protein secondary structure prediction and its application as a protein aggregation prediction tool","author":"Kouza","year":"2017"},{"key":"10.1016\/j.micpath.2022.105736_bib21","first-page":"1","article-title":"Prediction of protein structure and interaction by GALAXY protein modeling programs","volume":"2","author":"HeeShin","year":"2014","journal-title":"Biodes."},{"key":"10.1016\/j.micpath.2022.105736_bib22","doi-asserted-by":"crossref","DOI":"10.1002\/bmb.20457","article-title":"Proteopedia entry: Ramachandran plots","volume":"38","author":"Oberholser","year":"2010","journal-title":"Biochem. Mol. Biol. Educ."},{"key":"10.1016\/j.micpath.2022.105736_bib23","doi-asserted-by":"crossref","first-page":"W407","DOI":"10.1093\/nar\/gkm290","article-title":"ProSA-web: interactive web service for the recognition of errors in three-dimensional structures of proteins","volume":"35","author":"Wiederstein","year":"2007","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.micpath.2022.105736_bib24","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/pro.3330","article-title":"MolProbity: more and better reference data for improved all\u2010atom structure validation","volume":"27","author":"Williams","year":"2018","journal-title":"Protein Sci."},{"key":"10.1016\/j.micpath.2022.105736_bib25","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1186\/1471-2105-9-514","article-title":"ElliPro: a new structure-based tool for the prediction of antibody epitopes","volume":"9","author":"Ponomarenko","year":"2008","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.micpath.2022.105736_bib26","doi-asserted-by":"crossref","first-page":"W449","DOI":"10.1093\/nar\/gkaa379","article-title":"NetMHCpan-4.1 and NetMHCIIpan-4.0: improved predictions of MHC antigen presentation by concurrent motif deconvolution and integration of MS MHC eluted ligand data","volume":"48","author":"Reynisson","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.micpath.2022.105736_bib27","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1038\/ni.3850","article-title":"Germline bias dictates cross-serotype reactivity in a common dengue-virus-specific CD8+ T cell response","volume":"18","author":"Culshaw","year":"2017","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.micpath.2022.105736_bib28","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1126\/science.1215584","article-title":"Structural basis of TLR5-flagellin recognition and signaling","volume":"335","author":"Yoon","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.micpath.2022.105736_bib29","doi-asserted-by":"crossref","first-page":"3676","DOI":"10.1093\/bioinformatics\/btw514","article-title":"PRODIGY: a web server for predicting the binding affinity of protein\u2013protein complexes","volume":"32","author":"Xue","year":"2016","journal-title":"Bioinformatics"},{"key":"10.1016\/j.micpath.2022.105736_bib30","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1093\/protein\/8.2.127","article-title":"LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions","volume":"8","author":"Wallace","year":"1995","journal-title":"Protein Eng. Des. Sel."},{"key":"10.1016\/j.micpath.2022.105736_bib31","first-page":"82","article-title":"Pymol: an open-source molecular graphics tool","volume":"40","author":"DeLano","year":"2002","journal-title":"CCP4 Newsletter protein crystallography"},{"key":"10.1016\/j.micpath.2022.105736_bib32","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/s41577-020-00479-7","article-title":"A guide to vaccinology: from basic principles to new developments","volume":"21","author":"Pollard","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.micpath.2022.105736_bib33","doi-asserted-by":"crossref","DOI":"10.1038\/emm.2017.172","article-title":"Bacterial flagellin\u2014a potent immunomodulatory agent","volume":"49","author":"Hajam","year":"2017","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.micpath.2022.105736_bib34","doi-asserted-by":"crossref","first-page":"9247","DOI":"10.1073\/pnas.0502040102","article-title":"Evasion of Toll-like receptor 5 by flagellated bacteria","volume":"102","author":"Andersen-Nissen","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.micpath.2022.105736_bib35","doi-asserted-by":"crossref","first-page":"6922","DOI":"10.4049\/jimmunol.172.11.6922","article-title":"Flagellin promotes myeloid differentiation factor 88-dependent development of Th2-type response","volume":"172","author":"Didierlaurent","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.micpath.2022.105736_bib36","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.bbrc.2021.01.073","article-title":"The Nucleocapsid protein triggers the main humoral immune response in COVID-19 patients","volume":"543","author":"Smits","year":"2021","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.micpath.2022.105736_bib37","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41591-020-01194-5","article-title":"T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1\/2 clinical trial","volume":"27","author":"Ewer","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.micpath.2022.105736_bib38","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1016\/j.immuni.2021.06.018","article-title":"COVID-19 vaccine mRNA-1273 elicits a protective immune profile in mice that is not associated with vaccine-enhanced disease upon SARS-CoV-2 challenge","volume":"54","author":"DiPiazza","year":"2021","journal-title":"Immunity"},{"year":"2020","series-title":"Safety and Immunogenicity of the Ad26. COV2. S COVID-19 Vaccine Candidate: Interim Results of a Phase 1\/2a, Double-Blind, Randomized, Placebo-Controlled Trial","author":"Sadoff","key":"10.1016\/j.micpath.2022.105736_bib39"},{"key":"10.1016\/j.micpath.2022.105736_bib40","doi-asserted-by":"crossref","first-page":"6182","DOI":"10.3390\/molecules26206182","article-title":"In silico and in vivo evaluation of SARS-CoV-2 predicted epitopes-based candidate vaccine","volume":"26","author":"Shehata","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.micpath.2022.105736_bib41","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/s41586-021-04232-5","article-title":"A COVID-19 peptide vaccine for the induction of SARS-CoV-2 T cell immunity","volume":"601","author":"Heitmann","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.micpath.2022.105736_bib42","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2021.684152","article-title":"A peptide vaccine candidate tailored to individuals' genetics mimics the multi-targeted T cell immunity of COVID-19 convalescent subjects","volume":"12","author":"Somogyi","year":"2021","journal-title":"Front. Genet."}],"container-title":["Microbial Pathogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401022003497?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401022003497?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:41:58Z","timestamp":1760110918000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0882401022003497"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":42,"alternative-id":["S0882401022003497"],"URL":"https:\/\/doi.org\/10.1016\/j.micpath.2022.105736","relation":{},"ISSN":["0882-4010"],"issn-type":[{"type":"print","value":"0882-4010"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preparation and pre-clinical evaluation of flagellin-adjuvanted NOM vaccine candidate formulated with Spike protein against SARS-CoV-2 in mouse model","name":"articletitle","label":"Article Title"},{"value":"Microbial Pathogenesis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.micpath.2022.105736","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"105736"}}